Cancidas

Type: Product
Name: Cancidas
First reported 16 hours ago - Updated 16 hours ago - 1 reports

Genetic analysis of Candida glabrata shows new genetic sources of drug tolerance

The Max F. Perutz Laboratories in Vienna has coordinated agenetic study of Candida glabrata that has discovered 28 new genes that are partly responsible for the yeast'stolerance of common drugs.The working group led by Karl Kuchler at the Max F. Peru ... [Published MTB Europe - 16 hours ago]
First reported Aug 20 2014 - Updated Aug 20 2014 - 1 reports

Progress in the fight against harmful fungi

A group of researchers at the Max F. Perutz Laboratories has created one of the three world's largest gene libraries for the Candida glabrata yeast, which is harmful to humans. Molecular analysis of the Candida glabrata fungus mutations led to the discovery ... [Published PhysOrg.com - Aug 20 2014]
First reported Aug 07 2014 - Updated Aug 07 2014 - 1 reports

Human medicines European public assessment report (EPAR): Cancidas (previously Caspofungin MSD), caspofungin, Revision: 16, Authorised

Entities: Cancidas

Quotes

"Since genetically removing these virulence factors from a Candida glabrata patient isolates markedly reduces their"
...transmitters are the best points of attack for the development of new and highly effective anti-fungal therapies," says Karl Kuchler from the MFPL. "These findings represent a new milestone in the discovery and characterisation of Candida glabrata resistance genes, laying the foundations for the development of new anti-fungal medications. This means that, in future, it will be possible to treat the often fatal invasive infections with pathogenic fungi in a more targeted and efficient manner."

More Content

All (4) | News (3) | Reports (0) | Blogs (1) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Genetic analysis of Candida glabrata shows new ... [Published MTB Europe - 16 hours ago]
Progress in the fight against harmful fungi [Published PhysOrg.com - Aug 20 2014]
Human medicines European public assessment repo... [Published Pending EC decisions and European Public Assess ... - Aug 07 2014]
TrialNetworks Welcomes Global Pharmaceutical In... [Published PRWeb - Jan 16 2014]
1
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Human medicines European public assessment repo... [Published Pending EC decisions and European Public Assess ... - Aug 07 2014]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.